Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Nuclear Medicine

• Publication date

  2004-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 15471839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiolabeled RGD-DTPA-Tyr3-Octreotate for Receptor-Targeted Radionuclide Therapy

  2004influential reference
• Rationale for Sentinel Node Biopsy to Stage N0 Head and Neck Squamous-Cell Carcinoma

  2004cited by this paper
• Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.

  2003cited by this paper
• Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

  2002cited by this paper
• Integrins as targets of angiogenesis inhibition.

  2001cited by this paper
• Evaluation of a radiolabelled cyclic DTPA‐RGD analogue for tumour imaging and radionuclide therapy

  2000cited by this paper
• State of the art and future prospects in the management of neuroendocrine tumors.

  2000cited by this paper
• Glycoprotein IIb/IIIa Antagonists Induce Apoptosis in Rat Cardiomyocytes by Caspase-3 Activation*

  2000cited by this paper
• RGD peptides induce apoptosis by direct caspase-3 activation

  1999influential reference
• Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

  1999cited by this paper
• Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

  1999cited by this paper
• Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases*

  1999cited by this paper
• Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

  1998cited by this paper
• Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma

  1998cited by this paper
• Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.

  1997cited by this paper
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

  1993cited by this paper
• In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.

  1991cited by this paper
• Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1

  1991cited by this paper

• Elevating theranostics: The emergence and promise of radiopharmaceutical cell-targeting heterodimers in human cancers

  2024cites this paper
• Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme

  2021cites this paper
• Hybridization of tumor homing and mitochondria-targeting peptide domains to design novel dual-imaging self-assembled peptide nanoparticles for theranostic applications

  2021cites this paper
• Emerging trends of receptor-mediated tumor targeting peptides: A review with perspective from molecular imaging modalities.

  2021cites this paper
• Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy

  2020cites this paper
• Synthetic Peptide Drugs for Targeting Skin Cancer: Malignant Melanoma and Melanotic Lesions.

  2017cites this paper
• Imaging of Intracellular Targets

  2016cites this paper
• Preclinical evaluation of a bispecific low‐molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer

  2014cites this paper
• Low-Molecular HeterodimerTargeting Both PSMAandGRPR for Improved PETImaging andTherapyof ProstateCancer

  2014cites this paper
• Tetraamine-coupled peptides and resulting (99m)Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors.

  2013cites this paper
• Evaluation of A Novel Arg-Gly-Asp-Conjugated Alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Potential Melanoma Therapy

  2013influential citation
• Multivalency of non-peptide integrin αVβ3 antagonist slows tumor growth.

  2013cites this paper
• Development of RGD-based radiotracers for tumor imaging and therapy: translating from bench to bedside.

  2013cites this paper
• Radiolabeled Heterobivalent Peptidic Ligands: an Approach with High Future Potential for in vivo Imaging and Therapy of Malignant Diseases

  2013cites this paper
• Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

  2012cites this paper
• Optical and multimodal peptide-based probes for in vivo molecular imaging.

  2012cites this paper
• Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers.

  2012cites this paper
• Open Access RESEARCH

  2010cites this paper
• Targeted Auger Electron Radiotherapy of Malignancies

  2010cites this paper
• Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues.

  2010cites this paper
• Targeting the nucleus: an overview of Auger-electron radionuclide therapy.

  2010cites this paper
• Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide.

  2010cites this paper
• Dual-targeted molecular probes for cancer imaging.

  2010cites this paper
• Intracellular targets of RGDS peptide in melanoma cells

  2010cites this paper
• Peptide-receptor radionuclide therapy for endocrine tumors

  2009cites this paper
• Radiolabelled RGD peptides and peptidomimetics for tumour targeting.

  2009cites this paper
• Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.

  2009cites this paper
• Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.

  2009cites this paper
• 111In-Labeled Immunoconjugates (ICs) Bispecific for the Epidermal Growth Factor Receptor (EGFR) and Cyclin-Dependent Kinase Inhibitor, p27Kip1

  2009cites this paper
• Targeted Radionuclide Tumor Therapy

  2008cites this paper
• Peptides for Radionuclide Therapy

  2008cites this paper
• Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.

  2008cites this paper
• Update: Improvement Strategies for Peptide Receptor Scintigraphy and Radionuclide Therapy

  2008cites this paper
• Radiolabeled high affinity peptidomimetic antagonist selectively targets αvβ3 receptor-positive tumor in mice

  2007cites this paper
• Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.

  2007cites this paper
• Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

  2007cites this paper
• Radiolabelled regulatory peptides for imaging and therapy.

  2007cites this paper
• Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.

  2007cites this paper
• Bombesin and Neurotensin Receptor Targeting Using Radiolabeled Peptide Analogs

  2007cites this paper
• From combinatorial chemistry to cancer-targeting peptides.

  2007cites this paper
• Anticancer activity of targeted proapoptotic peptides.

  2006influential citation
• Structural and inhibitory properties of a plant proteinase inhibitor containing the RGD motif.

  2006cites this paper
• Polymeric Conjugates for Angiogenesis-Targeted Tumor Imaging and Therapy

  2006cites this paper
• Novel Approach in Radionuclide Tumor Therapy: Dose Enhancement by High Z-Element Contrast Agents

  2006cites this paper
• Octapeptide Analogs of Somatostatin Containing α,α-Dialkylated Amino Acids with Potent Anticancer Activity

  2006cites this paper
• Anticancer activity of modified somatostatin analogs

  2005cites this paper
• Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides.

  2005cites this paper